Much of what you read about IVF is written with one worry in mind: getting enough eggs. If you have polycystic ovary syndrome (PCOS), your consultation may sound different. Your doctor may talk about lowering doses, preventing an over-response, changing the trigger, and freezing embryos instead of transferring straight away. If that feels like the opposite of what you expected, it is because the main risk for many people with PCOS sits at the other end of the scale.
This guide explains how IVF is typically adapted for PCOS and for anyone your clinic describes as a "predicted high responder". It draws on the European Society of Human Reproduction and Embryology's ovarian stimulation guideline (ESHRE, 2025 update) and ASRM patient information. Your own plan should come from your doctor, who knows your history, blood results and scans.
Why PCOS changes the IVF plan
PCOS commonly comes with a high number of small resting follicles on ultrasound and a high AMH level. Those are the same markers clinics use to predict how strongly the ovaries will respond to stimulation. More follicles responding can mean more eggs, which sounds like good news, but it also raises the risk of ovarian hyperstimulation syndrome (OHSS). ASRM lists both a high AMH and PCOS (which its fact sheet notes is now also called PMOS) among the risk factors for OHSS (ReproductiveFacts, ASRM, 2023).
The response can also be unpredictable. Some people with PCOS go from very little visible activity to a sudden surge of follicles once a threshold dose is reached. That is why monitoring is often close and dose changes are made carefully.
Not everyone with a high response has PCOS, and not everyone with PCOS responds strongly. The planning principles below apply to anyone the clinic expects to respond strongly.
Step one: choosing the protocol
ESHRE's 2025 update recommends the GnRH antagonist protocol for predicted high responders. Antagonist protocols are also its general recommendation over agonist protocols for most IVF patients. The practical reason this matters so much for PCOS is flexibility at the end of stimulation: in an antagonist cycle, the clinic can use a GnRH agonist as the trigger shot, which is one of the main tools for preventing OHSS. That option is not available in the same way in a long agonist cycle.
The guideline also suggests that, within antagonist protocols, a fixed start day for the antagonist is probably preferable to a flexible start, though this is a conditional recommendation and clinics differ. Our protocols comparison explains how the antagonist schedule fits into a cycle.
Step two: a gentler starting dose
For predicted high responders, ESHRE suggests a reduced FSH starting dose in the range of 100 to under 150 IU to lower OHSS risk. It is a conditional recommendation based on limited evidence, so your clinic may choose differently based on your weight, age, AMH and any previous response.
If you have done a previous cycle, bring the details: starting dose, how many days you stimulated, your peak estradiol, number of follicles and eggs, and whether you had OHSS. That history is often more useful than any predictive marker.
What closer monitoring usually looks like
People expected to respond strongly may be scanned and have blood drawn more often, particularly in the second half of stimulation. Your team is watching both follicle numbers and estradiol to decide whether to hold or reduce your dose, and to choose the safest trigger. Our guide to monitoring bloodwork explains what those numbers mean.
Step three: the trigger and the transfer plan
This is where PCOS cycles most often differ from the standard script. ESHRE's 2025 guideline makes two strong recommendations here:
- For people at risk of OHSS, use a GnRH agonist trigger combined with freezing all embryos to minimise the risk of severe OHSS.
- Use a freeze-all strategy to reduce late-onset OHSS, the form that a pregnancy in the same cycle can drive.
It also suggests that adding hCG to an agonist trigger (a "dual trigger") is probably not recommended for high responders, and it prefers an agonist trigger over the older approach of "coasting" (pausing stimulation drugs to let hormone levels fall).
For many people with PCOS, then, the realistic expectation is: retrieval, then embryos frozen, then a transfer in a later cycle. The guideline also says that, for the general IVF population, a fresh transfer should be avoided after an agonist trigger, because luteal support is often insufficient after that trigger. That is a big part of why agonist triggers and freeze-all are paired.
Our comparison of fresh and frozen transfer covers the broader evidence on the two strategies.
What freeze-all means for your schedule
- You wait for your ovaries to settle and usually for a period before a transfer cycle starts.
- The frozen transfer needs its own preparation, either around your own ovulation or with medication. People with PCOS who ovulate irregularly may be more likely to be offered a medicated (programmed) approach; ask your clinic which they recommend and why. See our guide to natural versus medicated frozen transfer.
- If you are travelling for treatment, retrieval and transfer may become two separate trips, or the transfer may be done after a gap.
Add-ons and extras: what ESHRE advises against
People with PCOS are often offered, or read about, medications and supplements that promise to improve the response or egg quality. ESHRE's 2025 update looked at several of them for PCOS and high responders:
| Option | ESHRE 2025 position for PCOS / high responders |
|---|---|
| Metformin alongside an antagonist cycle | Probably not recommended routinely (conditional) |
| Letrozole added during stimulation | Probably not recommended for predicted high responders (conditional) |
| Clomiphene added during stimulation | Probably not recommended for predicted high responders (conditional) |
| Growth hormone | Not recommended for women with PCOS (strong) |
| Myo-inositol | Probably not recommended for PCOS (conditional) |
These positions are about using these options to improve IVF results during stimulation. Some people with PCOS take metformin or other medication for separate reasons, such as blood sugar management, prescribed by another doctor. Do not stop a medication on the basis of this table; ask your fertility doctor and the prescribing doctor how it fits with your IVF plan.
Life after retrieval when you have PCOS
Because high responders are the group most likely to develop OHSS, the days after retrieval deserve a plan. ASRM's fact sheet lists warning signs that should prompt a call, including weight gain of more than three pounds in two days, difficulty breathing, ongoing vomiting, trouble keeping fluids down, abdominal swelling and reduced urination. Our article on OHSS warning signs after retrieval covers home monitoring and what to do if symptoms progress.
ASRM also lists cabergoline among the tools clinics use to reduce OHSS risk, and ESHRE recommends dopamine agonists to reduce early OHSS, particularly when an hCG trigger has been used. If your clinic prescribes something after retrieval, ask what it is for and how long to take it.
A typical high-responder pathway, step by step
Every clinic has its own approach, but a plan built along ESHRE's recommendations often looks something like this:
- Baseline assessment: AMH, antral follicle count, review of any previous cycles.
- Antagonist protocol with a moderate starting dose of FSH.
- Close monitoring in the second half of stimulation, with doses held or reduced if response accelerates.
- Agonist trigger if there are many follicles or estradiol is high.
- Retrieval, then all suitable embryos frozen.
- Recovery, with OHSS symptom monitoring for about a week.
- Frozen embryo transfer in a later cycle once the ovaries have settled.
This is an illustration, not a prescription. Some people with PCOS respond moderately and may be offered a fresh transfer with an hCG trigger. Your clinic decides based on what actually happens during your stimulation.
If you are travelling for IVF with PCOS
- Expect more monitoring visits near the end of stimulation. If you plan to do early monitoring at home, agree how results will be shared and who can change your dose.
- Allow time after retrieval before flying home, because OHSS symptoms usually peak in the following week.
- Budget for a frozen transfer rather than assuming a fresh one, since freeze-all is common for high responders.
- Bring past cycle records, including your daily dose chart if you have it.
Questions to ask your clinic
- Do you consider me a predicted high responder, and based on what?
- Which protocol and starting dose are you planning, and why?
- Under what circumstances would you use an agonist trigger and freeze all embryos?
- What will you do if my response becomes very strong partway through?
- Are you recommending any additional medication or supplement, and what is the evidence for it?
- How would a frozen transfer be prepared for me if my cycles are irregular?
The bottom line
For PCOS and other high responders, a good IVF plan is built around control rather than maximum yield: an antagonist protocol, a modest starting dose, close monitoring, an agonist trigger when needed, and freezing embryos so the transfer happens in a calmer cycle. Many popular extras have weak or negative support in ESHRE's 2025 guideline. Plan for the possibility of two stages, retrieval and later transfer, and know the OHSS warning signs before you need them.
This site covers what — protocols, medications, add-ons, and what the evidence says about treatment itself. For where — destinations, donor laws, costs, and trip logistics, country by country — our sister site covers the map.
Compare destinations at ivfabroad.co →